We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging Alpha Cognition Inc. (ACOG) This Year?
Read MoreHide Full Article
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Alpha Cognition Inc. (ACOG - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Alpha Cognition Inc. is a member of the Medical sector. This group includes 950 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Alpha Cognition Inc. is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for ACOG's full-year earnings has moved 30% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that ACOG has returned about 8.2% since the start of the calendar year. At the same time, Medical stocks have gained an average of 6.5%. This means that Alpha Cognition Inc. is performing better than its sector in terms of year-to-date returns.
One other Medical stock that has outperformed the sector so far this year is Actinium Pharmaceuticals (ATNM - Free Report) . The stock is up 15.1% year-to-date.
The consensus estimate for Actinium Pharmaceuticals' current year EPS has increased 11.7% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Alpha Cognition Inc. belongs to the Medical - Biomedical and Genetics industry, a group that includes 467 individual stocks and currently sits at #91 in the Zacks Industry Rank. On average, stocks in this group have gained 19.9% this year, meaning that ACOG is slightly underperforming its industry in terms of year-to-date returns.
Actinium Pharmaceuticals, however, belongs to the Medical - Drugs industry. Currently, this 147-stock industry is ranked #79. The industry has moved +7.9% so far this year.
Investors interested in the Medical sector may want to keep a close eye on Alpha Cognition Inc. and Actinium Pharmaceuticals as they attempt to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Are Medical Stocks Lagging Alpha Cognition Inc. (ACOG) This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Alpha Cognition Inc. (ACOG - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Alpha Cognition Inc. is a member of the Medical sector. This group includes 950 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Alpha Cognition Inc. is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for ACOG's full-year earnings has moved 30% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that ACOG has returned about 8.2% since the start of the calendar year. At the same time, Medical stocks have gained an average of 6.5%. This means that Alpha Cognition Inc. is performing better than its sector in terms of year-to-date returns.
One other Medical stock that has outperformed the sector so far this year is Actinium Pharmaceuticals (ATNM - Free Report) . The stock is up 15.1% year-to-date.
The consensus estimate for Actinium Pharmaceuticals' current year EPS has increased 11.7% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Alpha Cognition Inc. belongs to the Medical - Biomedical and Genetics industry, a group that includes 467 individual stocks and currently sits at #91 in the Zacks Industry Rank. On average, stocks in this group have gained 19.9% this year, meaning that ACOG is slightly underperforming its industry in terms of year-to-date returns.
Actinium Pharmaceuticals, however, belongs to the Medical - Drugs industry. Currently, this 147-stock industry is ranked #79. The industry has moved +7.9% so far this year.
Investors interested in the Medical sector may want to keep a close eye on Alpha Cognition Inc. and Actinium Pharmaceuticals as they attempt to continue their solid performance.